Molecular Basis of Neurological Disorders

This quiz is designed to assess your understanding of the molecular basis of neurological disorders. It covers topics such as the genetic causes of neurological disorders, the molecular mechanisms underlying these disorders, and the development of therapeutic strategies.

15 Questions Published

Questions

Question 1 Multiple Choice (Single Answer)

Which of the following is a common genetic cause of Alzheimer's disease?

  1. Apolipoprotein E (APOE) gene
  2. Huntington's disease gene
  3. Parkinson's disease gene
  4. Amyotrophic lateral sclerosis (ALS) gene
Question 2 Multiple Choice (Single Answer)

What is the primary molecular mechanism underlying Huntington's disease?

  1. Expansion of a CAG repeat in the huntingtin gene
  2. Mutation in the alpha-synuclein gene
  3. Loss of dopamine neurons in the substantia nigra
  4. Accumulation of amyloid-beta plaques in the brain
Question 3 Multiple Choice (Single Answer)

Which neurotransmitter system is primarily affected in Parkinson's disease?

  1. Dopamine
  2. Serotonin
  3. Glutamate
  4. GABA
Question 4 Multiple Choice (Single Answer)

What is the main pathological hallmark of amyotrophic lateral sclerosis (ALS)?

  1. Accumulation of amyloid-beta plaques in the brain
  2. Formation of Lewy bodies in the substantia nigra
  3. Degeneration of motor neurons in the spinal cord and brain
  4. Loss of myelin sheaths around nerve fibers
Question 5 Multiple Choice (Single Answer)

Which of the following is a potential therapeutic strategy for Alzheimer's disease?

  1. Inhibition of amyloid-beta plaque formation
  2. Stimulation of dopamine production in the brain
  3. Replacement of lost motor neurons in the spinal cord
  4. Blocking the expansion of the CAG repeat in the huntingtin gene
Question 6 Multiple Choice (Single Answer)

What is the primary function of the huntingtin protein?

  1. Regulation of gene expression
  2. Transport of vesicles along microtubules
  3. Degradation of misfolded proteins
  4. Maintenance of mitochondrial function
Question 7 Multiple Choice (Single Answer)

Which brain region is primarily affected in Huntington's disease?

  1. Substantia nigra
  2. Caudate nucleus and putamen
  3. Cerebellum
  4. Hippocampus
Question 8 Multiple Choice (Single Answer)

What is the main component of Lewy bodies, the pathological hallmark of Parkinson's disease?

  1. Amyloid-beta
  2. Alpha-synuclein
  3. Tau protein
  4. Huntingtin protein
Question 9 Multiple Choice (Single Answer)

Which genetic mutation is associated with familial amyotrophic lateral sclerosis (ALS)?

  1. Mutation in the SOD1 gene
  2. Expansion of a CAG repeat in the huntingtin gene
  3. Mutation in the alpha-synuclein gene
  4. Mutation in the APOE gene
Question 10 Multiple Choice (Single Answer)

What is the role of glutamate in the pathogenesis of ALS?

  1. Glutamate excitotoxicity leads to neuronal damage
  2. Glutamate deficiency impairs motor neuron function
  3. Glutamate receptors are mutated in ALS patients
  4. Glutamate levels are increased in the cerebrospinal fluid of ALS patients
Question 11 Multiple Choice (Single Answer)

Which of the following is a potential therapeutic strategy for Parkinson's disease?

  1. Deep brain stimulation
  2. Administration of dopamine agonists
  3. Gene therapy to replace the mutated huntingtin gene
  4. Antioxidant therapy to reduce oxidative stress
Question 12 Multiple Choice (Single Answer)

What is the main function of the SOD1 protein?

  1. Detoxification of reactive oxygen species
  2. Regulation of gene expression
  3. Transport of vesicles along microtubules
  4. Maintenance of mitochondrial function
Question 13 Multiple Choice (Single Answer)

Which brain region is primarily affected in Alzheimer's disease?

  1. Hippocampus
  2. Substantia nigra
  3. Caudate nucleus and putamen
  4. Cerebellum
Question 14 Multiple Choice (Single Answer)

What is the primary function of the alpha-synuclein protein?

  1. Regulation of dopamine release and synaptic plasticity
  2. Transport of vesicles along microtubules
  3. Degradation of misfolded proteins
  4. Maintenance of mitochondrial function
Question 15 Multiple Choice (Single Answer)

Which of the following is a potential therapeutic strategy for ALS?

  1. Administration of riluzole to inhibit glutamate excitotoxicity
  2. Gene therapy to replace the mutated SOD1 gene
  3. Deep brain stimulation to modulate neuronal activity
  4. Antioxidant therapy to reduce oxidative stress